TWI:NYSETitan International, Inc. (DE) Analysis
Data as of 2026-06-12 - not real-time
$7.39
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Titan International (TWI) is trading at $7.39, just above its calculated support of $7 and well below its 200‑day SMA of $8.23, indicating a bearish price trend. The 20‑day SMA ($7.41) sits beneath the 50‑day SMA ($7.73), reinforcing the down‑trend, while the RSI of 47 suggests momentum is neutral but edging toward oversold territory. A modest bullish signal emerges from the MACD, where the line exceeds the signal and the histogram turns positive, hinting at a possible short‑term reversal. However, the stock’s 30‑day volatility exceeds 46 % and its beta above 1.7 signal a highly volatile, market‑sensitive profile. Fundamentally, revenue grew 2.9 % YoY to $1.84 bn, yet profit margins remain negative and free cash flow is still in the red, while debt‑to‑equity sits above 147 %, underscoring balance‑sheet pressure. The recent Q1 earnings miss on profitability, despite beating revenue estimates, sparked a 4 % intraday decline.
Valuation metrics paint a more attractive picture: a forward P/E of ~19.8 is well below the industry average of 30.4, the price‑to‑book ratio under 1 (0.92) and a price‑to‑sales of 0.26 suggest the stock is undervalued relative to peers. Analyst consensus is a strong‑buy with a median price target of $12, implying upside of roughly 59 % from current levels, and the Fear & Greed Index sits at “Extreme Greed,” reflecting bullish market sentiment. The lack of a dividend eliminates income expectations, and the high leverage combined with negative free cash flow raises sustainability concerns. Overall, the blend of technical weakness, elevated risk, and significant valuation upside creates a nuanced investment case.
Valuation metrics paint a more attractive picture: a forward P/E of ~19.8 is well below the industry average of 30.4, the price‑to‑book ratio under 1 (0.92) and a price‑to‑sales of 0.26 suggest the stock is undervalued relative to peers. Analyst consensus is a strong‑buy with a median price target of $12, implying upside of roughly 59 % from current levels, and the Fear & Greed Index sits at “Extreme Greed,” reflecting bullish market sentiment. The lack of a dividend eliminates income expectations, and the high leverage combined with negative free cash flow raises sustainability concerns. Overall, the blend of technical weakness, elevated risk, and significant valuation upside creates a nuanced investment case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support level
- high short‑term volatility
- recent earnings profitability miss
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- significant valuation upside to target price
- strong‑buy analyst consensus
- forward earnings improvement
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- structural demand for off‑highway equipment
- undervalued valuation multiples
- global geographic diversification
Key Metrics & Analysis
Financial Health
Revenue Growth2.90%
Profit Margin-4.72%
P/E Ratio19.8
ROE-16.42%
ROA0.80%
Debt/Equity147.25
P/B Ratio0.9
Op. Cash Flow$22.1M
Free Cash Flow$-13507750
Industry P/E30.4
Technical Analysis
TrendBearish
RSI47.0
Support$7.00
Resistance$7.88
MA 20$7.41
MA 50$7.73
MA 200$8.23
MACDBullish
VolumeStable
Fear & Greed Index87.86
Valuation
Target Price$11.75
Upside/Downside59.00%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.74
Volatility46.18%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.